Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,134 recalls, newest first

Class III · Low risk

Clofarabine injection

Labeling: Incorrect or Missing Package Insert: authorized generic product was packaged with the incorrect insert for the brand name product Clolar (clofarabine) injection.

Terminated Labeling / mix-up Sanofi-Aventis U.S. LLC NDC 0955-1746-01 D-0056-2018
Class II · Moderate risk

A1 Slim

Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared sibutramine, phenolphthalein, and n-desmethyl sibutramine, making this an unapproved drug for which safety and efficacy have not been established and therefore, subject to recall.

Terminated Chemical / undeclared Kiriko, LLC. D-0058-2018

Recalls by year